Scotia Capital Inc. Gilead Sciences, Inc. Transaction History

Scotia Capital Inc.

$17.8 Billion
Q3 2024

A detailed history of Scotia Capital Inc. transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Scotia Capital Inc. holds 148,624 shares of GILD stock, worth $13.6 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

148,624

Previous 150,192 1.04%

Holding current value

$13.6 Million

Previous $10.3 Million 20.89%

% of portfolio

0.07%

Previous 0.06%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$66.59 - $83.99 $104,413 - $131,696	-1,568 Reduced 1.04%	148,624 $12.5 Million
Q2 2024 Aug 14, 2024	SELL	$63.15 - $72.88 $2.51 Million - $2.9 Million	-39,741 Reduced 20.92%	150,192 $10.3 Million
Q1 2024 May 14, 2024	SELL	$71.58 - $87.29 $388,607 - $473,897	-5,429 Reduced 2.78%	189,933 $13.9 Million
Q4 2023 Feb 12, 2024	BUY	$73.27 - $83.09 $163,465 - $185,373	2,231 Added 1.16%	195,362 $15.8 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $110,540 - $120,601	-1,495 Reduced 0.77%	193,131 $14.5 Million
Q2 2023 Aug 03, 2023	SELL	$76.01 - $86.7 $947,008 - $1.08 Million	-12,459 Reduced 6.02%	194,626 $15 Million
Q1 2023 May 11, 2023	BUY	$77.31 - $88.08 $1.91 Million - $2.18 Million	24,705 Added 13.55%	207,085 $17.2 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $2.74 Million - $3.94 Million	-44,014 Reduced 19.44%	182,380 $15.7 Million
Q3 2022 Nov 10, 2022	BUY	$59.54 - $68.01 $2.54 Million - $2.91 Million	42,724 Added 23.26%	226,394 $14 Million
Q2 2022 Aug 05, 2022	SELL	$57.72 - $65.01 $68,744 - $77,426	-1,191 Reduced 0.64%	183,670 $11.4 Million
Q1 2022 May 09, 2022	BUY	$57.92 - $72.58 $2.81 Million - $3.53 Million	48,592 Added 35.66%	184,861 $11 Million
Q4 2021 Feb 11, 2022	SELL	$64.88 - $73.64 $170,958 - $194,041	-2,635 Reduced 1.9%	136,269 $9.89 Million
Q3 2021 Nov 12, 2021	BUY	$67.69 - $73.03 $260,132 - $280,654	3,843 Added 2.85%	138,904 $9.7 Million
Q2 2021 Aug 12, 2021	SELL	$63.47 - $69.35 $20,310 - $22,192	-320 Reduced 0.24%	135,061 $9.3 Million
Q1 2021 May 06, 2021	BUY	$60.0 - $68.46 $4.66 Million - $5.32 Million	77,708 Added 134.74%	135,381 $8.75 Million
Q4 2020 Feb 11, 2021	SELL	$56.65 - $64.55 $4.2 Million - $4.79 Million	-74,199 Reduced 56.27%	57,673 $3.36 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $109,668 - $137,889	1,766 Added 1.36%	131,872 $8.33 Million
Q2 2020 Aug 11, 2020	BUY	$72.34 - $84.0 $1.66 Million - $1.93 Million	22,993 Added 21.47%	130,106 $10 Million
Q1 2020 May 15, 2020	BUY	$62.63 - $80.22 $2.11 Million - $2.7 Million	33,719 Added 45.94%	107,113 $8.01 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $595,434 - $654,958	-9,663 Reduced 11.63%	73,394 $4.77 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $2.56 Million - $2.82 Million	-40,920 Reduced 33.01%	83,057 $5.26 Million
Q2 2019 Aug 13, 2019	BUY	$61.87 - $69.38 $95,341 - $106,914	1,541 Added 1.26%	123,977 $8.38 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $214,415 - $240,201	-3,429 Reduced 2.72%	122,436 $7.96 Million
Q4 2018 Feb 11, 2019	SELL	$60.54 - $79.0 $2.64 Million - $3.44 Million	-43,562 Reduced 25.71%	125,865 $7.87 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $1.8 Million - $1.99 Million	-25,229 Reduced 12.96%	169,427 $13.1 Million
Q2 2018 Aug 13, 2018	BUY	$64.88 - $75.68 $367,220 - $428,348	5,660 Added 2.99%	194,656 $14.6 Million
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $1.37 Million - $1.67 Million	18,792 Added 11.04%	188,996 $14.2 Million
Q4 2017 Feb 13, 2018	BUY	$71.15 - $83.52 $135,896 - $159,523	1,910 Added 1.13%	170,204 $12.2 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $1.58 Million - $1.87 Million	21,883 Added 14.95%	168,294 $13.6 Million
Q2 2017 Aug 15, 2017	BUY	N/A	146,411	146,411 $10.4 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $114B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Scotia Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Scotia Capital Inc. with notifications on news.

Account

Scotia Capital Inc. Gilead Sciences, Inc. Transaction History